Patents by Inventor Charles Malone

Charles Malone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230077338
    Abstract: An incident report management system is configured to receive and analyze incident reports relating to workplace accidents and injuries. A natural language processing function utilizes word dictionaries of varying type and scope to reduce an incident description to a set of core components that are far smaller than the input text while also preserving important aspects of the input text. The reduced core component set may be analyzed for meaning, compared to large volumes of historic incident reports, and otherwise processed more quickly and more efficiently whether by an expert function or AI function. In this manner, the system is able to provide real-time feedback during submission of incidents to improve quality and completeness, and after submission of incidents to notify users of serious incidents, provide dashboard analytics, and identify underlying and undiscovered risks in the workplace.
    Type: Application
    Filed: September 12, 2022
    Publication date: March 16, 2023
    Inventors: R Mukund, Matthew Bayuk, Natasha Porter, Vijay Alluru, Charles Malone
  • Publication number: 20040224958
    Abstract: This invention provides pyridopyrimidines and 4-aminopyrimidines that are useful for treating cell proliferatives disorders, such as cancer and restenosis. We have now discovered a group of 7,8-dihydro-2 (amino and thio)pyrido[2,3-d]pyrimidines and 2,4-diaminopyrimidines that are potent inhibitors of cyclin-dependent kinases (cdks) and growth factor-mediated kinases. The compounds are readily synthesized and can be administered by a variety of routes, including orally, and have sufficient bioavailability. This invention provides compounds of Formula (I) and Formula (II) where W is NH, S, SO, or SO2, R1 includes phenyl and substituted phenyl, R2 includes alkyl and cycloalkyl, R3 includes alkyl and hydrogen, R8 and R9 include hydrogen and alkyl, and Z is carboxy. This invention also provide pharmaceutical formulations comprising a compound of Formula (I or II) together with a pharmaceutically acceptable carrier, diluent, or excipient therefor.
    Type: Application
    Filed: November 12, 2002
    Publication date: November 11, 2004
    Inventors: Richard John Booth, Arindam Chatterjee, Thomas Charles Malone
  • Patent number: 6703391
    Abstract: A compound having the formula or a pharmaceutically acceptable salt thereof wherein R is hydrogen or hydroxy; R1 is hydrogen, alkyl, arylalkyl, (CH2)nOH, or (CH2)nNR7R8; R5 and R6 are each independently hydrogen, halogen, NO2, CN, CF3, SO2NR7R8, PO3R9R10, alkyl, alkenyl, alkynyl, (CH2)nCONR7R8, (CH2)nCO2R10, NHCOR11, A is a ring formed by the following: a-NR12—CHR13—CHR14-b, a-CHR13—CHR14—NR12-b, a-CHR13—NR12—CHR14-b, a-CHR14—CH2—NR12—CHR13-b, a-CHR13—NR12—CH2—CHR14-b, a-CH2—CH2—CHR13—NR12-b, a-NR12—CHR13—CHR12—CH2—CH2-b, a-CH2—CH2—NR12—CH2—CH2-b, a-CH2—CH2—CH2NR12—CH2-b, a-CH2—NR12—CH2—CH2-b a-CH2—CH2—CH2—CH2—NR12-b, a-NR12—CH2—CH2—CH2—CH2-b, The compounds are useful in the treatment of disorders responsive to the blockade of glutamic and
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: March 9, 2004
    Assignee: Neurosearch A/S
    Inventors: Christopher Franklin Bigge, Thomas Charles Malone, Frank Watjen
  • Patent number: 6474702
    Abstract: An oven door lock for self-cleaning ovens is described. The oven door lock includes a manually operated latch mechanism moveable from an unlatched state. In the latched state, a thermally responsive element is provided with a pin adapted to be received in a hole defined in the latch mechanism to lock the latch mechanism in the latched state during self-cleaning operation. The oven door lock is provided with a nuisance latch which prevents the latch mechanism from being moved to the latched state during non-self-cleaning use of the oven. A switch is provided to indicate when the latch mechanism is in the latched state. An insulation pad is sandwiched between the switch and a mounting bracket of the oven door lock to thermally and electrically insulate the switch from the oven door lock.
    Type: Grant
    Filed: August 16, 2000
    Date of Patent: November 5, 2002
    Assignee: France/Scott Fetzer Company
    Inventors: Charles Malone, James D. Livers, Jr., James Ramsey
  • Patent number: 6458781
    Abstract: The present invention provides compounds that block calcium channels and have the Formula I: The present invention also provides pharmaceutical compositions containing the compounds of Formula I and methods of using them to treat stroke, cerebral ischemia, head trauma, and epilepsy.
    Type: Grant
    Filed: October 25, 1999
    Date of Patent: October 1, 2002
    Inventors: David Thomas Connor, Lain-Yen Hu, Thomas Charles Malone, Michael Francis Rafferty, Bruce David Roth, Todd Robert Ryder, Anthony Denver Sercel, Yuntao Song
  • Patent number: 6423689
    Abstract: The present invention provides compounds that block calcium channels having the Formula I shown below. The present invention also provides methods of using the compounds of Formula I to treat stroke, cerebral ischemia, head trauma, or epilepsy and to pharmaceutical compositions that contain the compounds of Formula I.
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: July 23, 2002
    Assignees: Warner-Lambert Company, Neurex Corporation
    Inventors: Richard John Booth, Louis Brogley, Wayne Livingston Cody, David Thomas Connor, Harriet Wall Hamilton, John Xiaoqiang He, Lain-Yen Hu, Leonard Joseph Lescosky, Thomas Charles Malone, Laszlo Nadasdi, Michael Francis Rafferty, Bruce David Roth, Diego F. Silva, Yuntao Song, Balazs G. Szoke, Laszlo Urge
  • Patent number: 6197771
    Abstract: Novel N-substituted azacycloalkyl ring fused 2,3-quinoxalinediones represented by the formula: or a pharmaceutically acceptable salt thereof, are disclosed, wherein the formula variables R1, R2, X, Y, m and n are as defined herein. Also disclosed are methods of treatment using the same and intermediate compounds useful in the preparation thereof.
    Type: Grant
    Filed: February 7, 2000
    Date of Patent: March 6, 2001
    Assignee: Warner-Lambert Company
    Inventors: Christopher Franklin Bigge, Thomas Charles Malone, Robert Michael Schelkun, Chung Stephen Yi
  • Patent number: 6117841
    Abstract: The present invention provides compounds that block calcium channels having the Formula I shown below. ##STR1## The present invention also provides methods of using the compounds of Formula I to treat stroke, cerebral ischemia, head trauma, or epilepsy and to pharmaceutical compositions that contain the compounds of Formula I.
    Type: Grant
    Filed: January 19, 1999
    Date of Patent: September 12, 2000
    Assignee: Warner-Lambert Company
    Inventors: Lain-Yen Hu, Thomas Charles Malone, Laszlo Nadasdi, Michael Francis Rafferty, Todd Robert Ryder, Diego F. Silva, Yuntao Song, Balazs G. Szoke, Laszlo Urge
  • Patent number: 6057313
    Abstract: Novel N-substituted azacycloalkyl ring fused 2,3-quinoxalinediones are disclosed represented by the formula: ##STR1## or a pharmaceutically acceptable salt thereof, wherein R.sup.1 is hydrogen, alkyl or W-alkyl; X and Y are independently hydrogen, halogen, nitro, cyano, trifluoromethyl, SO.sub.2 CF.sub.3, SO.sub.2 R.sup.4, SO.sub.2 NR.sup.4 R.sup.5, alkyl, alkenyl, (CH.sub.2).sub.z CONR.sup.4 R.sup.5, (CH.sub.2).sub.z COOR.sup.4, or NHCOR.sup.4, wherein R.sup.4 and R.sup.5 are independently hydrogen, alkyl having 1 to 6 carbon atoms, cycloalkyl or W-alkyl, and z is an integer from 0 to 4; R.sup.2 is benzoyl, W, W-alkyl, COcycloalkyl, COalkyl-W, CONR.sup.3 alkyl, CONR.sup.3 -W, CONR.sup.3 alkyl-W, CSNR.sup.3 alkyl, CSNR.sup.3 alkyl-W, ##STR2## or a moiety derived from a common amino acid by removal of the --OH from the carboxyl group which is alpha to the amino, wherein --W is aryl, heteroaryl, or the heterocycles piperidinyl, piperazinyl, morpholinyl or pyrrolidinyl, wherein R.sup.
    Type: Grant
    Filed: June 5, 1997
    Date of Patent: May 2, 2000
    Assignee: Warner-Lambert Company
    Inventors: Christopher Franklin Bigge, Thomas Charles Malone, Robert Michael Schelkun, Chung Stephen Yi
  • Patent number: 4517426
    Abstract: A switch arm connector block for mounting a plurality of spring switchblades in a predetermined array for sequential cooperation with a timer cam and for providing a quick-disconnect connector for electrically connecting the blades to a wiring harness is disclosed. The connector block is formed by a plurality of insulating wafers which encapsulate a plurality of flat, parallel switchblades. The faces of the wafers are spaced from each other by projecting curbs around the perimeters of the wafers and window openings are provided in the wafers so that internal bussing may be provided in the block. End bussing is provided and the end bussing strips are covered by a protective cap having insulating fences for protecting the bussing strips.
    Type: Grant
    Filed: February 29, 1984
    Date of Patent: May 14, 1985
    Assignee: The Scott & Fetzer Company
    Inventors: James D. Edwards, Charles Malone